BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 17, 2006
View Archived Issues
Patient Death In ConjuChem Phase II Trial Halts Dosing
ConjuChem Biotechnologies Inc. discontinued dosing in a Phase II trial of its growth hormone product, DAC:GRF in HIV lipodystrophy, pending an investigation into the death of a patient. (BioWorld Today)
Read More
FDA Says Nastech's Calcitonin-Salmon Spray Not Approvable
Read More
Official 2006 List Of Buzzwords, Passé Terms, Fatigued Phrases
Read More
DeCode Stock Sale To Raise $30M For Multidrug Pipeline
Read More
Latest BioLineRx In-License: Oral Peptide Drug For Obesity
Read More
Other News To Note
Read More